Instruction for use: Thermo-rheumonI want this, give me price
ATX code M02AX10 Other drugs
Other non-narcotic analgesics, including non-steroidal and other anti-inflammatory drugs
Nosological classification (ICD-10)
G54.1 Disorders of lumbosacral plexus
Sciatica, Neurology radicular origin, spine Pathology, Sciatica lumbosacral, radiculoneuritis
M25.5 Pain in the joint
Arthralgia, Pain syndrome in musculo-articular diseases, Pain syndrome in osteoarthritis, Pain syndrome in osteoarthritis, Pain syndrome in acute inflammatory diseases of the musculoskeletal system, Pain syndrome in chronic inflammatory diseases of the musculoskeletal system, Pain in the joints, Soreness of the joints, Soreness of joints in severe physical exertion, Painful inflammatory joint damage, Painful conditions of the musculoskeletal system, Painful joint conditions, Painful traumatic affection of joints, Pain in the musculoskeletal system, Pain in Shoulder Joints, Pain in the joints, Joint pain, Joint pain with injuries, Musculoskeletal pain, Pain with osteoarthritis, Pain in the pathology of the joints, Pain in rheumatoid arthritis, Pain in chronic degenerative bone diseases, Pain in chronic degenerative joint diseases, Bone-joint pain, Joint pain, Arthritic pain of rheumatic origin, Articular pain syndrome, Joint pain, Rheumatic pain, Rheumatic pains
Spondyloarthrosis, spondylarthrosis, Diseases of the spinal column, spondylosis
Ishialgia, Neuralgia of the sciatic nerve, Sciatic neuritis
Myositis, Fibrositis Fibromyositis, Inflammatory disease of soft tissues
M71 Other bursopathies
Bursitis, Bursopathy, Diseases of soft tissues, Osteoarthritis in musculo-articular diseases, Inflammatory disease of soft tissues, Subacute bursitis
M77.9 Other unspecified
Capsule, Periarthritis, Tendonitis, Tendopathy, Periarthropathy
M79.0 Other unspecified rheumatism
Degenerative rheumatic disease, Degenerative and rheumatic diseases of the tendons, Degenerative rheumatic diseases, Localized forms of rheumatism of soft tissues, Rheumatism, Rheumatism with a pronounced allergic component, Rheumatism of the articular and extraarticular, Rheumatic attack, Rheumatic complaints, Rheumatic diseases, Rheumatic disease of the spine, Relapses of rheumatism, Articular and extra-articular rheumatism, Articular and muscular rheumatism, Articular rheumatism, Articular syndrome with rheumatism, Chronic rheumatic pain, Chronic articular rheumatism, Rheumatoid diseases, Rheumatic diseases of the intervertebral disc
Myofascial pain syndromes ,Pain syndrome in musculo-articular diseases, Pain syndrome in chronic inflammatory diseases of the musculoskeletal system, Pain in the muscles, Tenderness of muscles, Muscular soreness in severe physical exertion, Painful conditions of the musculoskeletal system, Pain in the musculoskeletal system, Pain in the muscles, Pain at rest, Muscle aches, Muscle pain, Musculoskeletal pain, Myalgia, Muscle pain, Muscle pain at rest, Muscle pain, Muscular pain of non-rheumatic origin, Muscle pain of rheumatic origin, Acute muscle pain, Rheumatic pain, Rheumatic pains, Myofascial syndrome, Fibromyalgia
Composition and form of release
1 g of cream contains etofenamata 100 mg and benzilnicotinate 10 mg; in tubes of 100 g.
Pharmacological action - anti-inflammatory, analgesic, antirheumatic.
It inhibits cyclooxygenase and reduces the formation of PG, reducing the manifestation of the inflammatory response and the sensitivity of pain receptors.
Rheumatic diseases of soft tissues and musculoskeletal system, myositis, myalgia, lumbago, sciatica, tendoaginitis, bursitis, painful spine and joint conditions caused by overload or degeneration (arthrosis, spondylosis).
Hypersensitivity, pregnancy, children's age.
Skin allergic reactions: itching, rash, erythema, vesiculation.
Dosing and Administration
Externally, the required amount (up to 2 g of cream) is applied and lightly circular movements rubbed on as much of the skin as possible 3-4 times a day. Course - 1-2 weeks.
Do not apply to mucous membranes, eyes and damaged or eczematous inflammation of the skin. Nursing mothers should refuse breastfeeding for the period of treatment.
Keep out of the reach of children.